nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
3.502 A comprehensive model of health-related quality of life in Parkinson's disease: Challenges for patient management
|
Visser, M. |
|
2007 |
13 |
Supplement 3 |
p. S187-S188 2 p. |
artikel |
2 |
1.278 Adult onset dystonic tremor as differential diagnosis for Parkinson's disease: Detailed clinical description of 20 patients emphasizing non-motor symptoms including olfactory function
|
Schwingenschuh, P. |
|
2007 |
13 |
Supplement 3 |
p. S70-S71 2 p. |
artikel |
3 |
Allied health care interventions and complementary therapies in Parkinson's disease
|
Nijkrake, M.J. |
|
2007 |
13 |
Supplement 3 |
p. S488-S494 7 p. |
artikel |
4 |
2.447 AMPA antagonists attenuate L-DOPA-induced abnormal involuntary movements in the 6-OHDA-lesioned rat model of Parkinson's disease
|
Kobylecki, C. |
|
2007 |
13 |
Supplement 3 |
p. S140- 1 p. |
artikel |
5 |
2.110 Association of PARKIN gene polymorphisms with Parkinson's disease in the Russian population
|
Demchuk, N. |
|
2007 |
13 |
Supplement 3 |
p. S94- 1 p. |
artikel |
6 |
3.314 Associations between the use of cueing specific guidelines and gait in Parkinson's disease: The RESCUE trial
|
Lim, I. |
|
2007 |
13 |
Supplement 3 |
p. S179- 1 p. |
artikel |
7 |
2.306 A yeast-based screening system for mouse brain proteins that modify the toxicity of alpha-synuclein
|
de Graeve, S. |
|
2007 |
13 |
Supplement 3 |
p. S123- 1 p. |
artikel |
8 |
2.450 Beneficial effects of the new multitargeting molecules BN82451 and BN83026 on tardive dyskinesia induced by haloperidol in rats
|
Auguet, M. |
|
2007 |
13 |
Supplement 3 |
p. S141- 1 p. |
artikel |
9 |
1.292 Beneficial impact of pramipexole on social functioning in patients with restless legs syndrome
|
Zesiewicz, T. |
|
2007 |
13 |
Supplement 3 |
p. S74- 1 p. |
artikel |
10 |
3.301 Causes of falls in retrospective and prospective study in Parkinson's disease patients
|
Rudzińska, M. |
|
2007 |
13 |
Supplement 3 |
p. S175- 1 p. |
artikel |
11 |
3.103 Change of the midbrain size in normal aging and progressive supranuclear palsy: An MRI study
|
Sung, Y.-H. |
|
2007 |
13 |
Supplement 3 |
p. S153- 1 p. |
artikel |
12 |
1.309 Clinical and molecular studies of patients screened for Huntington's disease in a movement disorders clinic from Brazil
|
Riccioppo, G. |
|
2007 |
13 |
Supplement 3 |
p. S79- 1 p. |
artikel |
13 |
Contents
|
|
|
2007 |
13 |
Supplement 3 |
p. vii- 1 p. |
artikel |
14 |
Continued efficacy and safety of subcutaneous apomorphine in patients with advanced Parkinson's disease
|
Pfeiffer, Ronald F. |
|
2007 |
13 |
Supplement 3 |
p. 93-100 8 p. |
artikel |
15 |
2.222 Continuous dopaminergic stimulation in advanced PD. Switching from apomorphine to duodopa: Which treatment is better?
|
Tamburin, S. |
|
2007 |
13 |
Supplement 3 |
p. S103- 1 p. |
artikel |
16 |
3.412 Current practice in occupational therapy for patients with Parkinson's disease
|
Sturkenboom, I. |
|
2007 |
13 |
Supplement 3 |
p. S183- 1 p. |
artikel |
17 |
2.205 Design of the A to Z (Agonists to Zelapar) trial: Adding orally disintegrating selegiline to dopamine agonists in patients with Parkinson's disease experiencing complications
|
Isaacson, S. |
|
2007 |
13 |
Supplement 3 |
p. S98- 1 p. |
artikel |
18 |
2.266 Detrimental effect of levodopa on sleep-dependent consolidation of an implicit learning task
|
Wailke, S. |
|
2007 |
13 |
Supplement 3 |
p. S116- 1 p. |
artikel |
19 |
Developing a PD Service
|
Baker, Mary G. |
|
2007 |
13 |
Supplement 3 |
p. S498-S500 3 p. |
artikel |
20 |
1.166 Diagnosis of personality structure and cognition in patients with Parkinson's disease
|
Schiavella, M. |
|
2007 |
13 |
Supplement 3 |
p. S50-S51 2 p. |
artikel |
21 |
3.014 Diagnostic value of meta-iodobenzyl-guanidine myocardial scintigraphy in the differential diagnosis of senile dementia of the Alzheimer type and Diffuse Lewy Body Disease
|
Versijpt, J. |
|
2007 |
13 |
Supplement 3 |
p. S149- 1 p. |
artikel |
22 |
Disturbed intracortical excitability in early Parkinson's disease is l-DOPA dose related: A prospective 12-month paired TMS study
|
Bareš, Martin |
|
2007 |
13 |
Supplement 3 |
p. 489-494 6 p. |
artikel |
23 |
2.321 Do chronic non-specific brain insults predispose to incidental Lewy Body Disease? An exploratory study
|
Frigerio, R. |
|
2007 |
13 |
Supplement 3 |
p. S127- 1 p. |
artikel |
24 |
2.239 Dose strength equivalence and dose proportionality demonstrated with ropinirole 24-hour prolonged release
|
Vearer, D. |
|
2007 |
13 |
Supplement 3 |
p. S108- 1 p. |
artikel |
25 |
1.152 Dribbling of saliva in Parkinson's disease: Clinical correlations
|
Lewis, H. |
|
2007 |
13 |
Supplement 3 |
p. S47- 1 p. |
artikel |
26 |
1.213 Dysarthria in progressive supranuclear palsy
|
Mallien, G. |
|
2007 |
13 |
Supplement 3 |
p. S63-S64 2 p. |
artikel |
27 |
Editorial Board
|
|
|
2007 |
13 |
Supplement 3 |
p. IFC- 1 p. |
artikel |
28 |
3.235 Effects of low-frequency stimulation of the subthalamic nucleus on movement in Parkinson's disease
|
Eusebio, A. |
|
2007 |
13 |
Supplement 3 |
p. S171- 1 p. |
artikel |
29 |
3.201 Enhanced survival and function of neural stem cells derived dopaminergic neurons under surveillance of olfactory ensheathing cells in parkinsonian rats
|
Shukla, S. |
|
2007 |
13 |
Supplement 3 |
p. S161- 1 p. |
artikel |
30 |
3.230 Exercise performance in Parkinson's disease before and 3 months after DBS-STN operation
|
Jørgensen, H.U. |
|
2007 |
13 |
Supplement 3 |
p. S170- 1 p. |
artikel |
31 |
3.304 Gait disorders and increase of the step variability for cerebrovascular diseases: Diagnostics using the computer hardware–software complex “Dorozhka”
|
Pokhabov, D. |
|
2007 |
13 |
Supplement 3 |
p. S176- 1 p. |
artikel |
32 |
Impact of physical therapy for Parkinson's disease: A critical review of the literature
|
Kwakkel, G. |
|
2007 |
13 |
Supplement 3 |
p. S478-S487 10 p. |
artikel |
33 |
1.199 Increased reaction time predicts deficit of explicit visual learning in the early stages of Parkinson's disease
|
Ghilardi, M.F. |
|
2007 |
13 |
Supplement 3 |
p. S59-S60 2 p. |
artikel |
34 |
2.IS.2.1 Dopamine agonists in controlling motor symptoms – clinical relevance of trials
|
Emre, M. |
|
2007 |
13 |
Supplement 3 |
p. S145- 1 p. |
artikel |
35 |
3.IS.4.3 How to start in your clinic? Implementation and practical guidelines
|
Munneke, M. |
|
2007 |
13 |
Supplement 3 |
p. S191- 1 p. |
artikel |
36 |
1.020 Is psychopathology part of the phenotypic spectrum of Myoclonus–Dystonia? A study of a large Dutch M-D family
|
Foncke, E. |
|
2007 |
13 |
Supplement 3 |
p. S32- 1 p. |
artikel |
37 |
2.252 Lisuride long term s.c. infusion in advanced Parkinson's disease patients unresponsive to oral treatments
|
Stocchi, F. |
|
2007 |
13 |
Supplement 3 |
p. S112- 1 p. |
artikel |
38 |
2.402 Low-dose pesticide exposure and early stages of Parkinsonism in a rat model
|
Vanbesien-Mailliot, C. |
|
2007 |
13 |
Supplement 3 |
p. S128- 1 p. |
artikel |
39 |
2.426 Mechanism of degradation of Bad protein by the green tea polyphenol (−)-epigallocatechin-3-gallate: Implication for neuroprotection
|
Kalfon, L. |
|
2007 |
13 |
Supplement 3 |
p. S134- 1 p. |
artikel |
40 |
Myoclonus
|
Caviness, John N. |
|
2007 |
13 |
Supplement 3 |
p. S375-S384 10 p. |
artikel |
41 |
NADPH oxidase inhibitor DPI is neuroprotective at femtomolar concentrations through inhibition of microglia over-activation
|
Qian, Li |
|
2007 |
13 |
Supplement 3 |
p. S316-S320 5 p. |
artikel |
42 |
Nitrous oxide promotes hyperhomocysteinemia in levodopa treated rats
|
Henninger, Nils |
|
2007 |
13 |
Supplement 3 |
p. 524-527 4 p. |
artikel |
43 |
1.126 Non-motor symptoms in akinesia dominant versus other phenotypes in Parkinson's disease (PD): Results form the international PD non-motor symptoms scale study
|
Naidu, Y. |
|
2007 |
13 |
Supplement 3 |
p. S40- 1 p. |
artikel |
44 |
Olfaction in Parkinson's Disease
|
Doty, Richard L. |
|
2007 |
13 |
Supplement 3 |
p. S225-S228 4 p. |
artikel |
45 |
1.112 Olfactory dysfunction in Parkinson's disease: Is extended testing useful to discriminate between patients and controls?
|
Boesveldt, S. |
|
2007 |
13 |
Supplement 3 |
p. S37- 1 p. |
artikel |
46 |
2.002 PD: Autonomic dysfunction
|
Reichmann, H. |
|
2007 |
13 |
Supplement 3 |
p. S87- 1 p. |
artikel |
47 |
3.426 PDCreativity.org: A web-based resource for improving the quality of life of people with Parkinson's disease
|
Stone, S. |
|
2007 |
13 |
Supplement 3 |
p. S186-S187 2 p. |
artikel |
48 |
1.001 PD: Motor and non-motor fluctuations
|
van Laar, T. |
|
2007 |
13 |
Supplement 3 |
p. S29- 1 p. |
artikel |
49 |
Peripheral trauma and movement disorders
|
van Hilten, Jacobus J. |
|
2007 |
13 |
Supplement 3 |
p. S395-S399 5 p. |
artikel |
50 |
2.269 Plasma homocysteine levels in idiopathic Parkinson's disease: Role of idiopathic Parkinson's disease and levodopa treatment
|
Ha, S.-W. |
|
2007 |
13 |
Supplement 3 |
p. S116- 1 p. |
artikel |
51 |
2.451 Possible antioxidant mechanisms of cyclooxygenase inhibitors against 3-nitropropionic acid induced neurotoxicity in rats
|
Kumar, A. |
|
2007 |
13 |
Supplement 3 |
p. S141- 1 p. |
artikel |
52 |
2.230 Pramipexole monotherapy in the treatment of early Parkinson's disease: Results of a 3 year follow up of a randomized controlled study
|
Oztekin, N. |
|
2007 |
13 |
Supplement 3 |
p. S106- 1 p. |
artikel |
53 |
Presynaptic plasticity: modulation of secretion, co-transmission and neurodegeneration
|
Verhage, Matthijs |
|
2007 |
13 |
Supplement 3 |
p. S250- 1 p. |
artikel |
54 |
2.416 Proteomic analysis of ventral midbrain in MPTP-treated normal and L1cam transgenic mice
|
Diedrich, M. |
|
2007 |
13 |
Supplement 3 |
p. S131-S132 2 p. |
artikel |
55 |
3.117 Raclopride PET in the differential diagnosis of multiple system atrophy and Parkinson's disease using discriminant analysis
|
Clerinx, K. |
|
2007 |
13 |
Supplement 3 |
p. S157-S158 2 p. |
artikel |
56 |
Recognition memory for unfamiliar faces in Parkinson's disease: Behavioral and electrophysiologic measures
|
Kida, Yasunobu |
|
2007 |
13 |
Supplement 3 |
p. 157-164 8 p. |
artikel |
57 |
2.021 Regulation of the iron-responsive proteins amyloid precursor protein and alpha-synuclein by green tea polyphenol (−)-epigallocatechin-3-gallate
|
Reznichenko, L. |
|
2007 |
13 |
Supplement 3 |
p. S91- 1 p. |
artikel |
58 |
2.317 Regulation of the iron-responsive proteins amyloid precursor protein and alpha-synuclein by green tea polyphenol (−)-epigallocatechin-3-gallate
|
Reznichenko, L. |
|
2007 |
13 |
Supplement 3 |
p. S126- 1 p. |
artikel |
59 |
1.326 Reversible general paresis and hippocampus hyperintensities after intensive neurosyphilis treatment: A case report
|
Fabiani, G. |
|
2007 |
13 |
Supplement 3 |
p. S83- 1 p. |
artikel |
60 |
1.295 Ropinirole CR significantly improves quality of life in patients with restless legs syndrome
|
Bogan, R. |
|
2007 |
13 |
Supplement 3 |
p. S75- 1 p. |
artikel |
61 |
2.236 Ropinirole used as an adjunct to levodopa is effective on motor function in Parkinson's disease
|
Oztekin, N. |
|
2007 |
13 |
Supplement 3 |
p. S107- 1 p. |
artikel |
62 |
1.197 Sequence learning and the basal ganglia
|
Ghilardi, M.F. |
|
2007 |
13 |
Supplement 3 |
p. S59- 1 p. |
artikel |
63 |
1.323 Siblings of SCA type 2 with heterogenous neurodegenerative disorders
|
Yabe, H. |
|
2007 |
13 |
Supplement 3 |
p. S82-S83 2 p. |
artikel |
64 |
1.169 Sleep disorders and depression among black Parkinson's disease patients: A study of 37 patients in University of Maiduguri Teaching Hospital
|
Nyandaiti, Y. |
|
2007 |
13 |
Supplement 3 |
p. S51- 1 p. |
artikel |
65 |
1.139 Sleep disturbance and daytime sleepiness in Flemish persons with Parkinson's disease
|
Kerckhofs, E. |
|
2007 |
13 |
Supplement 3 |
p. S43- 1 p. |
artikel |
66 |
1.136 Sleep-related problems in patients with Parkinson's disease
|
Lee, H.-W. |
|
2007 |
13 |
Supplement 3 |
p. S42-S43 2 p. |
artikel |
67 |
1.183 SPAARS approach: A new theoretical framework for self-injurious behavior
|
Khetrapal, N. |
|
2007 |
13 |
Supplement 3 |
p. S55- 1 p. |
artikel |
68 |
Spatial topography of the neurofibrillary tangles in cortical and subcortical regions in progressive supranuclear palsy
|
Armstrong, Richard A. |
|
2007 |
13 |
Supplement 3 |
p. 50-54 5 p. |
artikel |
69 |
SPECT imaging, immunohistochemical and behavioural correlations in the primate models of Parkinson's disease
|
Ashkan, Keyoumars |
|
2007 |
13 |
Supplement 3 |
p. 266-275 10 p. |
artikel |
70 |
Stereotactic surgery for subthalamic nucleus stimulation under general anesthesia: A retrospective evaluation of Japanese patients with Parkinson's disease
|
Yamada, Kazumichi |
|
2007 |
13 |
Supplement 3 |
p. 101-107 7 p. |
artikel |
71 |
3.218 Surgical treatment improving quality of life in Parkinson's disease
|
Singh, A. |
|
2007 |
13 |
Supplement 3 |
p. S166- 1 p. |
artikel |
72 |
The effect of cigarette smoking, tea, and coffee consumption on the progression of Parkinson's disease
|
Kandinov, Boris |
|
2007 |
13 |
Supplement 3 |
p. 243-245 3 p. |
artikel |
73 |
2.283 The frequency of cardiac valve regurgitation in Japanese patients with Parkinson's disease using pergolide
|
Kimura, K. |
|
2007 |
13 |
Supplement 3 |
p. S120- 1 p. |
artikel |
74 |
2.433 The possibility of kynurenine metabolites binding to ionotropic glutamate receptors and to calmodulin: data on molecular modeling and Drosophila kynurenic mutants
|
Zhuravlev, A. |
|
2007 |
13 |
Supplement 3 |
p. S136- 1 p. |
artikel |
75 |
Transcranial magnetic stimulation as a method for investigating the plasticity of the brain in Parkinson's Disease and dystonia
|
Rothwell, John |
|
2007 |
13 |
Supplement 3 |
p. S417-S420 4 p. |
artikel |
76 |
What you always wanted to know about … Early Markers in PD
|
W. Berendse, Henk |
|
2007 |
13 |
Supplement 3 |
p. S92- 1 p. |
artikel |
77 |
What you always wanted to know about … Medical history
|
Goldman, Jennifer |
|
2007 |
13 |
Supplement 3 |
p. S152- 1 p. |
artikel |
78 |
3.204 Zuckerkandl's organ improves long-term survival and function of neural stem cells derived dopaminergic neurons in Parkinsonian rats
|
Chaturvedi, R.K. |
|
2007 |
13 |
Supplement 3 |
p. S162-S163 2 p. |
artikel |